Robert Iervasi Buys 344,550 Shares of Vitura Health Limited (ASX:VIT) Stock

Vitura Health Limited (ASX:VIT) insider Robert Iervasi purchased 344,550 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The stock was acquired at an average cost of A$0.09 ($0.05) per share, with a total value of A$29,631.30 ($18,404.53).

Vitura Health Stock Performance

The firm has a market cap of $54.68 million, a P/E ratio of 15.84 and a beta of 0.16.

Vitura Health Company Profile

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations.